Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.
about
Functional Specialization of Skin Dendritic Cell Subsets in Regulating T Cell ResponsesTranscutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patchProtection against tetanus by needle-free inoculation of adenovirus-vectored nasal and epicutaneous vaccinesEffect of skin barrier disruption on immune responses to topically applied cross-reacting material, CRM(197), of diphtheria toxin.Langerhans cells as targets for immunotherapy against skin cancer.Transcutaneous immunization with hydrophilic recombinant gp100 protein induces antigen-specific cellular immune response.Langerhans cells cross-present antigen derived from skinDelivering vaccines into the skin without needles and syringes.Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cellsSkin dendritic cell targeting via microneedle arrays laden with antigen-encapsulated poly-D,L-lactide-co-glycolide nanoparticles induces efficient antitumor and antiviral immune responses.Transcutaneous antigen delivery system.Solid-in-oil nanodispersions for transdermal drug delivery systems.The Langerhans cell controversy: are they immunostimulatory or immunoregulatory cells of the skin immune system?Layer-by-layer-assembled multilayer films for transcutaneous drug and vaccine delivery.Immunization onto bare skin with synthetic peptides: immunomodulation with a CpG-containing oligodeoxynucleotide and effective priming of influenza virus-specific CD4+ T cells.Immunization without needles.Exosome-mediated regulation of tumor immunology
P2860
Q26777948-3D840C9E-9118-4519-B5D1-64BC98F429B7Q28252883-3D10AB29-0C15-47D6-8FE5-27977959E5C4Q33849814-75D445ED-B4CC-4BA9-BEBA-933C32CB9C1EQ33946811-677962C8-FC2D-470B-83FC-FA2FE4A16BCDQ34009436-F8857DB8-0332-4B7C-A9FB-AE87073D51B8Q34293564-E3FB529C-CFA7-4BBA-9FB5-D152208A3612Q34650867-0C0D286D-204F-4826-BD38-5FB706528329Q35623375-86252DA8-EE51-46D8-AC15-EA193EBF1655Q37221714-C3307603-ED6C-4CC6-AEE1-181259AEB1E1Q37607079-F4E8636A-B463-4E32-9BDE-BC3FCF52DE76Q38076804-A82BAD19-1AF0-4F11-A80C-66E00536D5B7Q38830870-01403295-68F1-4BB7-9B79-F48881EACE28Q39882251-78212F9D-2DA6-407F-B22E-507684506BDCQ41877534-D9890940-F10E-4E47-A1D3-D9B506A82324Q44191604-4A022720-5461-4C90-88A9-BB64AA9C0F01Q46308392-A16DADBF-FE44-4BE2-AC1B-0E7C0DDF81DFQ58804155-5219207E-C7C8-4C95-A1C6-5D96135BE62B
P2860
Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2000
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@en
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@nl
type
label
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@en
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@nl
prefLabel
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@en
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@nl
P2093
P2860
P356
P1476
Percutaneous peptide immunizat ...... ental tumor immunoprophylaxis.
@en
P2093
P2860
P304
P356
10.1073/PNAS.97.1.371
P407
P577
2000-01-01T00:00:00Z